Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
45,417,667
-
Shares change
-
+602,121
-
Total reported value, excl. options
-
$25,020,191
-
Value change
-
+$41,852
-
Put/Call ratio
-
231%
-
Number of buys
-
31
-
Number of sells
-
-37
-
Price
-
$0.5491
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q4 2021
99 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q4 2021.
iBio, Inc. - Common Stock (IBIO) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45,417,667 shares
.
Largest 10 shareholders include BlackRock Inc. (15,475,418 shares), VANGUARD GROUP INC (10,573,840 shares), STATE STREET CORP (4,553,819 shares), GEODE CAPITAL MANAGEMENT, LLC (3,771,565 shares), NORTHERN TRUST CORP (1,901,858 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,182,744 shares), Nuveen Asset Management, LLC (906,306 shares), Bank of New York Mellon Corp (739,269 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (532,143 shares), and GOLDMAN SACHS GROUP INC (365,389 shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.